The estimated Net Worth of Ran Gorelik is at least $370 Mille dollars as of 15 March 2024. Ran Gorelik owns over 55,723 units of Cronos Inc stock worth over $370,038 and over the last 3 years Ran sold CRON stock worth over $0.
Ran has made over 8 trades of the Cronos Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Ran exercised 55,723 units of CRON stock worth $121,476 on 15 March 2024.
The largest trade Ran's ever made was exercising 150,000 units of Cronos Inc stock on 16 November 2022 worth over $363,000. On average, Ran trades about 29,977 units every 83 days since 2022. As of 15 March 2024 Ran still owns at least 169,742 units of Cronos Inc stock.
You can see the complete history of Ran Gorelik stock trades at the bottom of the page.
Ran's mailing address filed with the SEC is 111 PETER STREET, SUITE 300, , TORONTO, A6, M5V 2H1.
Over the last 4 years, insiders at Cronos Inc have traded over $30,495,757 worth of Cronos Inc stock and bought 1,848,320 units worth $4,899,192 . The most active insiders traders include Michael Ryan Gorenstein, Jason Marc Adler e Jeffrey David Jacobson. On average, Cronos Inc executives and independent directors trade stock every 15 days with the average trade being worth of $528,456. The most recent stock trade was executed by James Andrew Iii Mc Ginness on 29 August 2024, trading 14,618 units of CRON stock currently worth $31,867.
cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.
Cronos Inc executives and other stock owners filed with the SEC include: